<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03573453</url>
  </required_header>
  <id_info>
    <org_study_id>CT0012018</org_study_id>
    <nct_id>NCT03573453</nct_id>
  </id_info>
  <brief_title>Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients.</brief_title>
  <acronym>COINN</acronym>
  <official_title>Comparison of Continuous Versus Intermittent Enteral Nutrition in Critically Ill Patients. Effect on Energy and Protein Target Achievement, Tolerance and Incidence of Complications. Monocentric Prospective Randomised Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Masaryk University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Brno University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Masaryk University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to compare continuous versus intermittent strategy for enteral
      nutrition. The study will examine if there is a difference in achieving nutritional delivery
      goals, tolerance and number of complications of enteral nutrition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will commence following the Approval by The Ethics Research Committee. All patients
      admitted to our ICU from the 1st of June 2018 to the 31st of May 2019 will be enrolled after
      fulfilling the inclusion criteria and in the absence of any exclusion criteria. Informed
      consent will be requested. Enteral nutrition will be administered via nasogastric of
      orogastric tube. Patients will be randomised in 2 groups. In the group of patients receiving
      continuous feeding will be enteral nutrition administered via enteral feeding pump for at
      least 16 hours par day. In the group of patients receiving intermittent feeding will be
      enteral nutrition administered as 30-60minutes lasting bolus via enteral feeding pump 6 times
      per day. Following the administration of the bolus the patient will be placed for 30 minutes
      in semi-upright sitting position. Enteral nutrition requirement and composition will be
      standardised with the adoption of international guidelines. In 5 subsequent days from the
      enteral nutrition commencement will be examined if there is a difference in achieving energy
      and protein targets, tolerance and number of complications of enteral nutrition in between
      both groups. As achievement of energy and protein targets will be considered at least 80% of
      calculated values. The tolerance of enteral nutrition will be evaluated by the clinical
      examination of the abdomen, presence of diarrhoea, vomiting and the gastric residual volume
      of at least 0,5 liter. As the complications of enteral nutrition will be regarded the
      aspiration of gastric contents and ventilator associated pneumonia. Nutritional status
      parameters will be analysed. the length of hospital stay, ICU length of stay and 28-day
      mortality will be also monitored.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 25, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Energy target</measure>
    <time_frame>5 days from initiation of enteral nutrition</time_frame>
    <description>Daily assessment of energy intake in critically ill patients with enteral nutrition.Energy target will be achieved if at least 80% of calculated energy intake will be delivered.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Protein target</measure>
    <time_frame>5 days from initiation of enteral nutrition</time_frame>
    <description>Daily assessment of protein intake in critically ill patients with enteral nutrition.Protein target will be achieved if at least 80% of calculated protein intake will be delivered.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of enteral nutrition</measure>
    <time_frame>5 days from initiation of enteral nutrition</time_frame>
    <description>Measurement of the gastric residual volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of enteral nutrition</measure>
    <time_frame>5 days from initiation of enteral nutrition</time_frame>
    <description>Incidence of diarrhoea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance of enteral nutrition</measure>
    <time_frame>5 days from initiation of enteral nutrition</time_frame>
    <description>Incidence of vomiting</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of enteral nutrition</measure>
    <time_frame>5 days from initiation of enteral nutrition</time_frame>
    <description>Incidence of aspiration and ventilator associated pneumonia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>On admission and day 5 from initiation of enteral nutrition</time_frame>
    <description>Blood test : total serum protein test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>On admission and day 5 from initiation of enteral nutrition</time_frame>
    <description>Blood test : albumin test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status</measure>
    <time_frame>On admission and day 5 from initiation of enteral nutrition</time_frame>
    <description>Blood test : prealbumin test</description>
  </secondary_outcome>
  <other_outcome>
    <measure>ICU and hospital length of stay</measure>
    <time_frame>through study completion, an average of 3 weeks</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>28-day mortality</measure>
    <time_frame>28 days from randomisation</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Nutrition Disorders</condition>
  <arm_group>
    <arm_group_label>Intermittent</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>enteral nutrition will be administered via enteral feeding pump as 30-60minutes lasting bolus 6 times per day volume of initial bolus will be 80ml. The volume of bolus will be increased gradually according to tolerance, till the estimated target rate will be reached</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>enteral nutrition will be administered via enteral feeding pump for at least 16 hours par day initial rate will be 25ml/hour. The rate will be increased gradually according to tolerance, till the estimated target rate will be reached</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>enteral nutrition</intervention_name>
    <description>administration of enteral nutrition</description>
    <arm_group_label>Continuous</arm_group_label>
    <arm_group_label>Intermittent</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age between 18 - 80 years

          -  indication of enteral nutrition with nasogastric or orogastric tube

          -  Nutrition Risk in the Critically Ill (NUTRIC) score â‰¥5

          -  Body mass index between 18 - 50

          -  mechanical ventilation expected for at least 72 hours

        Exclusion Criteria:

          -  upper gastrointestinal tract surgery in previous medical history

          -  bowel obstruction

          -  bowel ischemia

          -  acute pancreatitis

          -  severe diarrhoea (&gt;1l/24hours)

          -  gastrointestinal bleeding

          -  short bowel syndrome

          -  malabsorption syndrome in previous medical history

          -  ongoing enteral nutrition on admission to ICU
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roman Gal, prof MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Masaryk University Brno</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ondrej Hrdy, MD</last_name>
    <phone>+420 532 232 305</phone>
    <email>Hrdy.Ondrej@fnbrno.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Vach, MD</last_name>
    <phone>+420 532 233 850</phone>
    <email>Vach.Robert@fnbrno.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Brno and Masaryk University Brno</name>
      <address>
        <city>Brno</city>
        <zip>62500</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ondrej Hrdy, M.D.</last_name>
      <phone>+420532232305</phone>
      <email>hrdy.ondrej@fnbrno.cz</email>
    </contact>
    <contact_backup>
      <last_name>Petr Suk, M.D.</last_name>
      <phone>+420532232305</phone>
      <email>suk.petr@fnbrno.cz</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 17, 2018</study_first_submitted>
  <study_first_submitted_qc>June 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 29, 2018</study_first_posted>
  <last_update_submitted>February 19, 2020</last_update_submitted>
  <last_update_submitted_qc>February 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Critical Care</keyword>
  <keyword>Enteral Nutrition</keyword>
  <keyword>Ventilator Associated Pneumonia</keyword>
  <keyword>Gastric Residual Volume</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nutrition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

